Why the study?
Diagnosing HFpEF is particularly challenging in individuals with obesity due to symptom overlap and diagnostic limitations, highlighting a need for a tailored diagnostic approach.
This review highlights the specific challenges of diagnosing HFpEF in obese patients and proposes a tailored diagnostic algorithm to improve accuracy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for obese HFpEF diagnosis; prospective validation required before clinical adoption.
The rising prevalence of obesity and its association with heart failure with preserved ejection fraction (HFpEF) highlight an urgent need for a diagnostic approach tailored to this population. Diagnosing HFpEF is hampered by the lack of a single non-invasive diagnostic criterion. While this makes a firm diagnosis of HFpEF already notoriously difficult in the general population, it is even more challenging in individuals with obesity. The challenges stem from a range of factors, including the use of body mass index as a conceptually suboptimal indicator of health risks associated with increased body mass, symptom overlap between HFpEF and obesity, limitations in physical examination, difficulties in electrocardiographic and echocardiographic evaluation, and reduced diagnostic sensitivity of natriuretic peptides in individuals with obesity. In this review, we examine these diagnostic challenges and propose a diagnostic algorithm specifically tailored to improve the accuracy and reliability of HFpEF diagnosis in this growing patient demographic.
No takes yet. Share an insight, caveat, or question.
Dalen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: